These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 26330688)

  • 1. A Lipidomic Readout of Disease Progression in A Diet-Induced Mouse Model of Nonalcoholic Fatty Liver Disease.
    Sanyal AJ; Pacana T
    Trans Am Clin Climatol Assoc; 2015; 126():271-88. PubMed ID: 26330688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipidomic analysis of the liver from high-fat diet induced obese mice identifies changes in multiple lipid classes.
    Eisinger K; Krautbauer S; Hebel T; Schmitz G; Aslanidis C; Liebisch G; Buechler C
    Exp Mol Pathol; 2014 Aug; 97(1):37-43. PubMed ID: 24830603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased diacylglycerols characterize hepatic lipid changes in progression of human nonalcoholic fatty liver disease; comparison to a murine model.
    Gorden DL; Ivanova PT; Myers DS; McIntyre JO; VanSaun MN; Wright JK; Matrisian LM; Brown HA
    PLoS One; 2011; 6(8):e22775. PubMed ID: 21857953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development.
    Lai YS; Chen WC; Kuo TC; Ho CT; Kuo CH; Tseng YJ; Lu KH; Lin SH; Panyod S; Sheen LY
    J Agric Food Chem; 2015 Sep; 63(35):7873-84. PubMed ID: 26262841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Study of Multiple Stages Progressing to Nonalcoholic Steatohepatitis with Subsequent Fibrosis in SD Rats.
    Wang L; Wu S; Cai M; Ma J; Li S; Li M; Xu Y; Wei L; Shang J
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28820447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adzuki bean ameliorates hepatic lipogenesis and proinflammatory mediator expression in mice fed a high-cholesterol and high-fat diet to induce nonalcoholic fatty liver disease.
    Kim S; Hong J; Jeon R; Kim HS
    Nutr Res; 2016 Jan; 36(1):90-100. PubMed ID: 26773785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
    Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
    J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saturated fat and cholesterol are critical to inducing murine metabolic syndrome with robust nonalcoholic steatohepatitis.
    Mells JE; Fu PP; Kumar P; Smith T; Karpen SJ; Anania FA
    J Nutr Biochem; 2015 Mar; 26(3):285-92. PubMed ID: 25577467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovering a critical transition state from nonalcoholic hepatosteatosis to nonalcoholic steatohepatitis by lipidomics and dynamical network biomarkers.
    Sa R; Zhang W; Ge J; Wei X; Zhou Y; Landzberg DR; Wang Z; Han X; Chen L; Yin H
    J Mol Cell Biol; 2016 Jun; 8(3):195-206. PubMed ID: 26993042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of hepatic lipid profiles in a mouse model with nonalcoholic steatohepatitis and subsequent fibrosis.
    Saito K; Uebanso T; Maekawa K; Ishikawa M; Taguchi R; Nammo T; Nishimaki-Mogami T; Udagawa H; Fujii M; Shibazaki Y; Yoneyama H; Yasuda K; Saito Y
    Sci Rep; 2015 Aug; 5():12466. PubMed ID: 26289793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel diet-induced murine model of steatohepatitis with fibrosis for screening and evaluation of drug candidates for nonalcoholic steatohepatitis.
    Ejima C; Kuroda H; Ishizaki S
    Physiol Rep; 2016 Nov; 4(21):. PubMed ID: 27821715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
    Ding Y; Sun X; Chen Y; Deng Y; Qian K
    Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dietary fatty acids and cholesterol excess on liver injury: A lipidomic approach.
    Serviddio G; Bellanti F; Villani R; Tamborra R; Zerbinati C; Blonda M; Ciacciarelli M; Poli G; Vendemiale G; Iuliano L
    Redox Biol; 2016 Oct; 9():296-305. PubMed ID: 27639112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty acid composition in serum correlates with that in the liver and non-alcoholic fatty liver disease activity scores in mice fed a high-fat diet.
    Wang XH; Li CY; Muhammad I; Zhang XY
    Environ Toxicol Pharmacol; 2016 Jun; 44():140-50. PubMed ID: 27179602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
    Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J
    World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a novel mouse model of hepatocellular carcinoma with nonalcoholic steatohepatitis using a high-fat, choline-deficient diet and intraperitoneal injection of diethylnitrosamine.
    Kishida N; Matsuda S; Itano O; Shinoda M; Kitago M; Yagi H; Abe Y; Hibi T; Masugi Y; Aiura K; Sakamoto M; Kitagawa Y
    BMC Gastroenterol; 2016 Jun; 16(1):61. PubMed ID: 27296438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ursodeoxycholyl Lysophosphatidylethanolamide modifies aberrant lipid profiles in NAFLD.
    Pathil A; Liebisch G; Okun JG; Chamulitrat W; Schmitz G; Stremmel W
    Eur J Clin Invest; 2015 Sep; 45(9):925-31. PubMed ID: 26108973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis.
    Simon Y; Kessler SM; Gemperlein K; Bohle RM; Müller R; Haybaeck J; Kiemer AK
    World J Gastroenterol; 2014 Dec; 20(47):17839-50. PubMed ID: 25548482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease.
    Chang X; Wang Z; Zhang J; Yan H; Bian H; Xia M; Lin H; Jiang J; Gao X
    J Transl Med; 2016 Sep; 14():266. PubMed ID: 27629750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Female spontaneously diabetic Torii fatty rats develop nonalcoholic steatohepatitis-like hepatic lesions.
    Ishii Y; Motohashi Y; Muramatsu M; Katsuda Y; Miyajima K; Sasase T; Yamada T; Matsui T; Kume S; Ohta T
    World J Gastroenterol; 2015 Aug; 21(30):9067-78. PubMed ID: 26290633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.